Daron Evans

CIK 1411726 · CFO · last filed 2026-03-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.12M

Companies

4

Total Filings

70

Lifetime Open-Market Net

$739.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RZLT CFO 411,462 $4.00 $1.65M $664.7K 18 2026-03-04
NEPH CEO Specialty Renal Products 143,162 $3.34 $478.2K $59.9K 8 2021-06-01
CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted Chief Financial Officer 13,352 $0 4 2011-04-19
CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted Chief Financial Officer 13,352 $13.96 $186.4K $14.7K 9 2010-02-17

Recent Filings · Page 4 of 7

70 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-04-12 Buy (P) +79,000 $35.5K
2018-02-22 Grant (A) $0
2017-12-22 Grant (A) +180,000 $0
2017-09-06 Buy (P) +29,580 $7.2K
2017-08-23 Buy (P) +4,000 $1.0K
2017-08-11 Buy (P) +70,000 $18.2K
2017-06-13 Buy (P) +21,461 $5.6K
2017-05-19 Buy (P) +30,000 $7.7K
2017-04-04 Grant (A) +17,756 $0
2017-03-21 Buy (P) +83,332 $0
Showing 3140 of 70
Page 4 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.